Xiaoyong Fu
6PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.Agostina Nardone, Xintao Qiu, Sandor Spisak
|Nov 18, 2021
Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic.Xiaoyong Fu, Carmine De Angelis, Rachel Schiff
|Feb 04, 2021
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo
|May 20, 2020
Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.Mingjun Bi, Zhao Zhang, Yi-Zhou Jiang
|Dec 13, 2019
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer.Xiaoyong Fu, Resel Pereira, Carmine De Angelis
|Oct 10, 2019
In vivo longitudinal imaging of RNA interference-induced endocrine therapy resistance in breast cancer.Nrusingh C Biswal, Xiaoyong Fu, Jaidip M Jagtap
Pageof 1
Frequent Collaborators
3 joint publications
Rachel Schiff
2 joint publications
Rinath Jeselsohn
1 joint publications
Nrusingh C Biswal
1 joint publications
Myles Brown
1 joint publications
Mingjun Bi
1 joint publications
Zhao Zhang
1 joint publications
Pengya Xue
1 joint publications
Carmine De Angelis
1 joint publications
Wei Li
1 joint publications
Lizhen Chen
